1. Home
  2. CYTK vs HII Comparison

CYTK vs HII Comparison

Compare CYTK & HII Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cytokinetics Incorporated

CYTK

Cytokinetics Incorporated

N/A

Current Price

$76.84

Market Cap

10.7B

Sector

Health Care

ML Signal

N/A

Logo Huntington Ingalls Industries Inc.

HII

Huntington Ingalls Industries Inc.

N/A

Current Price

$327.56

Market Cap

11.5B

Sector

Industrials

ML Signal

N/A

Company Overview

Basic Information
Metric
CYTK
HII
Founded
1997
1886
Country
United States
United States
Employees
N/A
44000
Industry
Biotechnology: Pharmaceutical Preparations
Marine Transportation
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
10.7B
11.5B
IPO Year
2004
2010

Fundamental Metrics

Financial Performance
Metric
CYTK
HII
Price
$76.84
$327.56
Analyst Decision
Strong Buy
Buy
Analyst Count
19
6
Target Price
$89.26
$411.33
AVG Volume (30 Days)
1.7M
538.5K
Earning Date
05-05-2026
05-05-2026
Dividend Yield
N/A
1.52%
EPS Growth
N/A
10.24
EPS
N/A
9.06
Revenue
$13,368,000.00
$12,484,000,000.00
Revenue This Year
$7.37
$4.82
Revenue Next Year
$310.19
$6.28
P/E Ratio
N/A
$36.51
Revenue Growth
N/A
8.23
52 Week Low
$34.60
$262.66
52 Week High
$88.31
$460.00

Technical Indicators

Market Signals
Indicator
CYTK
HII
Relative Strength Index (RSI) 45.54 66.90
Support Level $73.95 $295.64
Resistance Level $79.66 $333.07
Average True Range (ATR) 2.91 12.11
MACD -0.37 3.96
Stochastic Oscillator 33.77 93.59

Price Performance

Historical Comparison
CYTK
HII

About CYTK Cytokinetics Incorporated

Cytokinetics Inc is a late-stage biopharmaceutical company focused on discovering, developing, and commercializing first-in-class muscle activators and next-in-class muscle inhibitors as potential treatments for debilitating diseases in which muscle performance is compromised and/or declining. The company develops treatments for diseases such as amyotrophic lateral sclerosis, heart failure, spinal muscular atrophy, and chronic obstructive pulmonary disease. The company's product, named as MYQORZO, is an allosteric and reversible inhibitor of cardiac myosin motor activity. The company is developing muscle-directed investigational medicines that may potentially improve the health span of people with devastating cardiovascular and neuromuscular diseases of impaired muscle function.

About HII Huntington Ingalls Industries Inc.

Huntington Ingalls Industries is the largest independent military shipbuilder in the US, spun out from Northrop Grumman in 2011. It operates three segments, two of which are storied shipyards: Ingalls produces non-nuclear-powered ships, including amphibious landing ships and Arleigh Burke-class destroyers, while Newport News produces nuclear-powered ships as the only producer of Gerald Ford-class aircraft carriers and a major subcontractor on Virginia- and Columbia-class nuclear submarines. HII shares production of destroyers and nuclear submarines with General Dynamics' Bath Iron Works and Electric Boat shipyards, respectively. The company's mission technologies segment produces uncrewed sea vessels and provides a range of IT and other services to US government agencies.

Share on Social Networks: